Company Profile
Season Entity Ltd was located in London UK. The joint stock and holding companies found in America, Russia and China. The company is specializing in pharmaceutical intermeiate, API and foumulation product and also chemical equipment and instrument etc.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
1-(2-AMINOETHYL)-4-CHLOROBENZENE |
Benzeneethanamine,4-chloro-;Phenethylamine,p-chloro-;4-Chlorobenzeneethanamine;p-Chloro-β-phenylethylamine;4-Chloro-β-phenylethylamine;p-Chlorophenethylamine;2-(p-Chlorophenyl)ethylamine;4-Chlorophenethylamine;4-Chloro-β-phenethylamine;[(4-Chlorophenyl)ethyl]amine;1-Amino-2-(p-chlorophenyl)ethane;2-(p-Chlorophenyl)-1-ethylamine;p-Chlorophenylethylamine;2-(4-Chlorophenyl)ethylamine;2-(4-Chlorophenyl)ethanamine;2-(4-Chlorophenyl)ethan-1-amine |
156-41-2 | - / 98% | Inquiry |
1-[[2-(4-Chlorophenyl)ethyl]amino]-2-chloropropane |
Benzeneethanamine,4-chloro-N-(2-chloropropyl)-,hydrochloride (1:1) |
953789-37-2 | - / 98% | Inquiry |
ANACETRAPIB |
2-Oxazolidinone,5-[3,5-bis(trifluoromethyl)phenyl]-3-[[4′-fluoro-2′-methoxy-5′-(1-methylethyl)-4-(trifluoromethyl)[1,1′-biphenyl]-2-yl]methyl]-4-methyl-,(4S,5R)-;(4S,5R)-5-[3,5-Bis(trifluoromethyl)phenyl]-3-[[4′-fluoro-2′-methoxy-5′-(1-methylethyl)-4-(trifluoromethyl)[1,1′-biphenyl]-2-yl]methyl]-4-methyl-2-oxazolidinone;(4S,5R)-5-[3,5-Bis(trifluoromethyl)phenyl]-3-[[4′-fluoro-5′-isopropyl-2′-methoxy-4-(trifluoromethyl)biphenyl-2-yl]methyl]-4-methyl-1,3-oxazolidin-2-one;Anacetrapib;MK 0859 |
875446-37-0 | - / 98% | Inquiry |
DABRAFENIB |
Benzenesulfonamide,N-[3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro-;N-[3-[5-(2-Amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide;Dabrafenib;GSK 2118436;Dabarefenib;Tafinlar;GSK 436;N-[3-[5-(2-Aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide;Tafmlar |
1195765-45-7 | - / 98% | Inquiry |
DABRAFENIB MESYLATE; GSK2118436B |
Benzenesulfonamide,N-[3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro-,methanesulfonate (1:1);Dabrafenib mesylate;GSK 2118436 methanesulfonate salt;GSK 2118436B;N-[3-[5-(2-Aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide methanesulfonic acid |
1195768-06-9 | - / 98% | Inquiry |
VORTIOXETINE HYDROBROMIDE; Lu AA21004 (HBr) |
Piperazine,1-[2-[(2,4-dimethylphenyl)thio]phenyl]-,hydrobromide (1:1);Lu AA 21004 hydrobromide;Vortioxetine hydrobromide;1-[2-[(2,4-Dimethylphenyl)thio]phenyl]piperazine hydrobromide;2361026-23-3 |
960203-27-4 | - / 99% | Inquiry |
VORTIOXETINE; Lu AA21004 |
Piperazine,1-[2-[(2,4-dimethylphenyl)thio]phenyl]-;1-[2-[(2,4-Dimethylphenyl)thio]phenyl]piperazine;Vortioxetine;Lu AA 21004;1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine;Brintellix;Trintellix |
508233-74-7 | - / 99% | Inquiry |
CONTACT INFORMATION
Sign In for Details